VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 110 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $235,000 | -17.3% | 25,207 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $284,000 | -12.9% | 25,207 | +10.7% | 0.00% | +50.0% |
| Q4 2014 | $326,000 | -89.5% | 22,771 | -88.1% | 0.00% | -87.5% |
| Q2 2014 | $3,097,000 | +55.1% | 191,435 | +55.9% | 0.02% | +60.0% |
| Q1 2014 | $1,997,000 | +33.0% | 122,810 | +1.4% | 0.01% | +11.1% |
| Q4 2013 | $1,502,000 | – | 121,066 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |